Advanced Gastroesophageal Junction Cancer

1 clinical trials · Condition

Record	Firm	Date
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification (NCT06585488)	BeOne Medicines	2024-12-13

Every clearance here is in the API, with alerts when new ones post.